View by type:
Articles (4217)
The world's last smallpox patient
Smallpox was one of the deadliest diseases in the world, but it’s the only one in history to have been eradicated globally. One Somali man sat on the frontline of this effort and can inspire the world today as we battle yet another devastating…
What are 'adverse events' and 'emergency use authorisation' in relation to vaccination?
While vaccines are the safest way to prevent the spread of infectious disease, a tiny proportion of those vaccinated may experience an adverse event. Here, we explain how often this happens and why.
Here’s how we could stop antimicrobial resistance becoming the next pandemic
Antimicrobial resistance was already a major global health threat, but now the potential increase in the use of antibiotics in response to the pandemic could exacerbate the problem and threaten a potentially even bigger global crisis.
What’s the most effective face mask for preventing COVID-19 transmission?
Face coverings have become a standard feature of pandemic life, but which mask is best for everyday use, and how should you take care of it?
Protecting Lower-Income Countries with COVID-19 Vaccines Requires Global Solidarity
The medical and moral imperative for equitable access to COVID-19 vaccines is why COVAX was created. Co-led by Gavi, the Vaccine Alliance, together with the World Health Organization (WHO) and the Coalition for Epidemic Preparedness…
4 things about mRNA COVID vaccines researchers still want to find out
Researchers are already working to improve the current crop of mRNA vaccines. Hopefully this will help them become more practical and affordable for the entire world, not just first-world countries.
How COVID-19 is altering cold and flu seasons
Pandemic restrictions and wider use of flu vaccines may have explained 2020’s record low cases of seasonal flu, but will the picture look like in tropical countries with year-round flu?
COVAX Statement on New Variants of SARS-CoV-2
The emergence of variants of SARS-CoV-2, the virus that causes COVID-19, serve as a powerful reminder that viruses by their very nature mutate, and that the scientific response may need to adapt if they are to remain effective against them.
How the Oxford-AstraZeneca vaccine could still help the battle against the COVID-19 variant
Research suggesting that one of the COVID-19 vaccines provides only minimal protection against mild-moderate infection caused by the 501.Y.V2 variant has raised concerns. But this doesn’t mean it won’t prevent severe disease and deaths.
Eliminating cervical cancer depends on global effort to ensure supply meets demand
Global access to HPV vaccine is vital, particularly in lower-income countries. Lessons learned from HPV roll-out could boost uptake of COVID-19 vaccines.
Why even a low efficacy COVID-19 vaccine could still be extremely useful
Efficacy rates for COVID-19 vaccines are higher than many scientists had dared dream of, but even if they prove less effective in real life, or in the face of new variants, they could still unlock normal life.
Who can’t have a COVID-19 vaccine?
The currently available coronavirus vaccines have been tested on adults of various ages, as well as those with long-term conditions, and appear to be safe. But there are a few groups who should avoid being vaccinated for now.